EVOTEC SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.21 EUR | -0.15% |
|
-1.12% | -37.92% |
| Apr. 17 | Evotec Names First Chief People Officer | MT |
| Apr. 17 | Evotec SE Welcomes Aurélie Dalbiez as Chief People Officer, Effective 15 June 2024 | CI |
Chart calendar Evotec SE
7679701a322c1c82fee035b.NjB3cnt1xlgmF9k-LIidTadKqI3PujblLfv1RXEZMXM.BVwwS0gskxNkcaANQePzOchnn_6u7Xm3d6yBIyNqZglvbzotTjP_CWFeiA~1b73d8bd7a3362eb3bbe15d1a489cd4c
Upcoming events on Evotec SE
Past events on Evotec SE
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-03-20 | Jefferies Pan-European Mid-Cap Conference |
| 2024-03-05 | TD Cowen Health Care Conference |
| 2024-01-22 09:00 am | Business Update Call |
| 2024-01-16 | UniCredit Kepler Cheuvreux German Corporate Conference |
| 2024-01-14 | ODDO BHF Forum |
| 2024-01-08 | Commerzbank and ODDO BHF German Investment Conference |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-04 | Berenberg European Conference |
| 2023-11-26 | German Equity Forum |
| 2023-11-15 | Jefferies London Healthcare Conference |
| 2023-11-15 03:00 am | Capital Markets Day |
| 2023-11-08 08:00 am | Q3 2023 Earnings Call |
| 2023-11-08 01:20 am | Q3 2023 Earnings Release |
| 2023-10-01 | RBC Virtual CDMO Conference |
| 2023-09-17 | Berenberg & Goldman Sachs German Corporate Conference |
| 2023-09-12 12:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-10 | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 | Citi BioPharma Conference |
| 2023-09-04 | Commerzbank & ODDO BHF Corporate Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 375 370 1.5% | 446 430 3.85% | 501 480 4.32% | 618 579 6.7% | 751 738 1.86% | 780 |
|
EBITDA Million EUR | Released Forecast Spread | 95,5 88,0 8.49% | 123 114 8.38% | 107 107 -0.63% | 107 108 -1.02% | 102 104 -2.29% | 68,4 |
|
EBIT Million EUR | Released Forecast Spread | 77,5 64,8 19.59% | 62,6 59,7 4.77% | 48,5 50,8 -4.47% | 41,0 41,9 -2.23% | 20,9 21,0 -0.93% | -39,5 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 72,0 65,4 10.17% | 56,6 51,0 10.83% | 25,8 28,7 -10.2% | 237 276 -14.2% | -154 -126 -21.99% | -60,1 |
|
Net income Million EUR | Released Forecast Spread | 84,2 61,1 37.67% | 38,1 33,0 15.37% | 6,25 15,7 -60.09% | 216 251 -14.24% | -176 -136 -28.92% | -54,7 |
|
EPS EUR | Released Forecast Spread | 0,56 0,41 35.92% | 0,25 0,22 13.64% | 0,04 0,10 -61.76% | 1,30 1,49 -12.85% | -0,99 -0,68 -45.54% | -0,30 |
| Announcement Date | 28/03/19 | 26/03/20 | 25/03/21 | 12/04/22 | 12/05/23 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 231 226 2.03% | 160 157 1.63% | 187 144 29.88% | 165 151 9.19% | 172 162 6.2% | 337 329 2.52% | 174 184 -5.58% | 241 220 9.36% | 170 160 6.29% | 384 372 3.18% | 196 172 13.96% | 205 | 216 | 224 | 241 | 260 | |
|
EBITDA Million EUR | Released Forecast Spread | 47,3 50,8 -6.95% | 37,2 45,5 -18.16% | 18,9 28,2 -33.05% | 14,7 19,9 -26.27% | 33,6 34,7 -3.07% | 11,0 33,7 -67.48% | 57,1 | 21,6 | 23,9 | 26,1 34,0 -23.24% | 24,1 19,5 23.44% | 23,6 | |||||
|
EBIT Million EUR | Released Forecast Spread | 18,9 22,6 -16.3% | 14,9 28,8 -48.15% | 0,46 11,0 -95.79% | -3,77 1,19 -415.7% | -3,31 -3,20 -3.34% | -13,5 13,2 -202.49% | 37,7 39,8 -5.34% | -3,90 | -36,3 0,97 -3823.68% | -12,2 -2,96 -311.46% | -2,28 | ||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -17,8 45,6 -139.11% | -24,3 0,20 -12268% | -43,4 7,90 -648.91% | -17,5 15,6 -212.66% | -5,20 | -20,4 -0,60 -3306.17% | -29,9 -4,08 -632.88% | 0,00 | |||||||||
|
Net income Million EUR | Released Forecast Spread | -31,5 24,1 -230.4% | -73,2 10,8 -778.56% | -27,9 -10,4 -168.63% | -101 -92,8 -9.03% | -47,3 12,8 -470.52% | -27,2 23,2 -217.4% | -5,20 | -14,9 9,55 -256.32% | -28,8 -28,0 -2.96% | -39,0 -6,19 -529.7% | -0,07 | ||||||
|
EPS EUR | Released Forecast Spread | -0,20 0,14 -242.86% | -0,41 | -0,16 -0,06 -166.67% | -0,57 -0,53 -7.55% | -0,27 0,02 -1450% | -0,15 -0,03 -400% | -0,03 | -0,08 -0,11 27.27% | -0,22 -0,05 -340% | -0,04 | -0,04 | -0,01 | 0,05 | 0,10 | |||
| Announcement Date | 12/08/20 | 12/11/21 | 12/04/22 | 11/05/22 | 11/08/22 | 11/08/22 | 09/11/22 | 12/05/23 | - | 29/08/23 | 29/08/23 | 08/11/23 | - | - | - | - | - |
More events
Past sector events for Evotec SE
| Today | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
| 2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVT Stock
- Calendar Evotec SE
